This news is delayed by 15 minutes, sign up now to get live news & full features.
INSM INSMED INC
+ add to watchlist
$201.15
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Mkt Cap: $42B
52 Week High: $212.75
P/E: -16.37
52 Week Low: $60.40
Dividend: $0.00
Shares Outstanding: 213.27M